CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Cephalon Inc. v. Agila Specialties Inc.

1:13-cv-02080

Overview

Case Number 1:13-cv-02080
Filing Date 2013-12-20
Status Terminated
Termination Date 2015-11-19
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Agila Specialties Inc. Operating Company

Represented By

4 Attorneys Listed

Mary Matterer

Attorney

Tel: +1 (302) 888-6800
Fax: +1 (302) 571-1750

Onco Therapies Limited NPE (University / Research)

Represented By

1 Attorneys Listed

Mary Matterer

Attorney

Tel: +1 (302) 888-6800
Fax: +1 (302) 571-1750

Plaintiff

Cephalon Inc. Operating Company

Represented By

6 Attorneys Listed

Richard D. Kirk

Attorney

Tel: +1 (302) 655-5000
Fax: +1 (302) 658-6395

Sara E. Bussiere

Attorney

Tel: +1 (302) 655-5000

Stephen B. Brauerman

Bayard, P.A.

Tel: +1 (302) 655-5000
Fax: +1 (302) 658-6395

600 N. King St., Suite 400, Wilmington, DE 19801

Vanessa Ribeiro Tiradentes

Gould & Ratner LLP

Tel: +1 (312) 899-1628

222 N. LaSalle St., Suite 800, Chicago, IL 60601

Counter Claimant

Agila Specialties Inc. Operating Company

Represented By

4 Attorneys Listed

Mary Matterer

Attorney

Tel: +1 (302) 888-6800
Fax: +1 (302) 571-1750

Onco Therapies Limited NPE (University / Research)

Represented By

1 Attorneys Listed

Mary Matterer

Attorney

Tel: +1 (302) 888-6800
Fax: +1 (302) 571-1750

Counter Defendant

Cephalon Inc. Operating Company

Represented By

6 Attorneys Listed

Richard D. Kirk

Attorney

Tel: +1 (302) 655-5000
Fax: +1 (302) 658-6395

Sara E. Bussiere

Attorney

Tel: +1 (302) 655-5000

Stephen B. Brauerman

Bayard, P.A.

Tel: +1 (302) 655-5000
Fax: +1 (302) 658-6395

600 N. King St., Suite 400, Wilmington, DE 19801

Vanessa Ribeiro Tiradentes

Gould & Ratner LLP

Tel: +1 (312) 899-1628

222 N. LaSalle St., Suite 800, Chicago, IL 60601

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 10 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts Counterparts in force
🏛️
USPTO PTAB Trials 1 proceeding
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (10): 🇺🇸 US
Parallel Proceedings Across Jurisdictions (1 found):
PTAB: 1
USPTO PTAB Trial 2014-12-24
IPR2015-00503

AGILA SPECIALTIES INC. v. Cephalon, Inc.

Asserted Patent
Status: Terminated-Settled
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

2 Patents

There are 2 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US8445524
Solid forms of bendamustine hydrochloride
Filed: 2011-11-22
Issued: 2013-05-21
Active (5.0 yrs remaining)
Expires: 2031-11-22
US8436190
Bendamustine pharmaceutical compositions
Filed: 2006-01-12
Issued: 2013-05-07
Active (3.9 yrs remaining) +1748d PTA
Expires: 2030-10-26

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Active Threat

Active Threat — Patent is within enforceable statutory term; injunctive relief viable.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

7

Dispositive

1

Granted

0

Denied

0

Pending / Review

2

Motions by Category

Procedural / Extension Motion 4 Claim Construction / Markman Filing 2 Motion to Dismiss 1

Key Dispositive Motions & Rulings

Motion to Dismiss Pending
Remark : Cases are consolidated for all purposes. All future filings shall be made only in lead CA 13-2046 GMS, including documents relating to the pending Moti...
Entry #— • 2014-11-24
Claim Construction / Markman Filing Pending
SO ORDERED - Proposed Scheduling Order filed by Cephalon, Inc. Setting Scheduling Order Deadlines: Cases are consolidated for all purposes. All future filings s...
Entry #— • 2014-11-24
Claim Construction / Markman Filing Pending
Minute Entry for proceedings held before Judge Gregory M. Sleet - Scheduling Conference held on 10/30/2014. These cases are consolidated for all purposes. Couns...
Entry #— • 2014-10-31
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME for Defendants to answer, move or otherwise respond to the Complaint to April 22, 2014 - filed by Agila Specialties Inc., Onco Therap...
Entry #12 • 2014-04-08 Document →
Procedural / Extension Motion Pending
SO ORDERED, re 12 STIPULATION TO EXTEND TIME for Defendants to answer, move or otherwise respond to the Complaint to April 22, 2014 filed by Onco Therapies Limi...
Entry #— • 2014-04-08
Procedural / Extension Motion Pending
SO ORDERED, re 7 STIPULATION TO EXTEND TIME for Defendant Agila Specialties Inc. f/k/a Strides, Inc. to respond to the complaint to April 8, 2014 filed by Agila...
Entry #— • 2014-01-14

Docket Entries

(59 total)
Pleading / Complaint

COMPLAINT filed against Agila Specialties Inc., Onco Therapies Limited - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1430575.) - filed by Cephalon Inc.. (Attachments: # 1 Exhibit A part 1, # 2 Exhibit A part 2, # 3 Exhibit B part 1, # 4 Exhibit B part 2, # 5 Civil Cover Sheet)(cla, ) (Entered: 12/23/2013)

Entry #1 • 2013-12-20
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (cla, ) (Entered: 12/23/2013)

Entry #2 • 2013-12-20
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 11/13/13. Date of Expiration of Patent: 3/26/29.Thirty Month Stay Deadline: 5/13/2016. (cla, ) (Main Document 3 replaced on 12/23/2013) (cla, ). Modified on 12/23/2013 (cla, ). (Entered: 12/23/2013)

Entry #3 • 2013-12-20
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,445,524; 8,436,190;. (cla, ) (Entered: 12/23/2013)

Entry #4 • 2013-12-20
1

Summons Issued with Magistrate Consent Notice attached as to Agila Specialties Inc. on 12/23/2013; Onco Therapies Limited on 12/23/2013. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (cla, )

Entry #5 • 2013-12-23
1
No Actions

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc